Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
04. September 2024 07:30 ET
|
Plus Therapeutics Inc.
Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Update: Oncology Pharma Signed a Letter of Intent with Kalos Therapeutics for an Exclusive World-Wide License and Co-Development of Its Broad-Spectrum Anti-Cancer Drug, KTH 222
19. August 2019 08:24 ET
|
Oncology Pharma, Inc.
SAN FRANCISCO, CA, Aug. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Oncology Pharma (OTCPK: ONPH)is pleased to announce that it signed a Letter of Intent with Kalos Therapeutics (Phoenix, AZ)...